Alvotech PIPE Financing Round Overshoots By $21m
Icelandic Firm Now Anticipates $475m Gross Proceeds Via SPAC Merger
Executive Summary
“Testament to the strong interest we have received from long-term investors as we continue our business combination with Oaktree II,” Alvotech is now set to raise in excess of $175m from an upsized PIPE financing round, representing $21m of additional commitments.
You may also be interested in...
Alvotech Acquires Reykjavik Manufacturing Facility Amid $136m Financing Boost
Months after it become a public company, Alvotech has once again turned to the debt/equity markets to provide financial firepower for its pipeline of biosimilar candidates.
Alvotech Chases Debt Backup As Shareholders Redeem From The Pot
Alvotech is furthering efforts to have a debt facility in place worth up to $125m as it kicks off life as a public company, amid challenging global market conditions.
Icelandic Exchange Approves Alvotech As Its Shares Trade In NY
Alvotech is celebrating an “historic milestone” as it became a publicly listed company in New York, with its shares set to also trade in its domestic Iceland next week.